Published in

Elsevier, The Lancet Oncology, 1(21), p. 105-120, 2020

DOI: 10.1016/s1470-2045(19)30668-0

Links

Tools

Export citation

Search in Google Scholar

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Journal article published in 2020 by Michiel S. van der Heijden, Daniel P. Petrylak, Alexandra Drakaki, Ronald de Wit, Kim N. and Drakaki Alexandra Chi, Cora N. Sternberg, Hiroyuki Nishiyama, Daniel Castellano, Andrea Necchi, Syed A. Hussain, Aude Fléchon, Aristotelis Bamias, Ivor J. Percent, Jae-Lyun Lee, Evan Y. Yu and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO